Evidence map›Paper›PMID 34583938›Full record

ArticleImmunoHorizons2021

Distal

Maday G Figueroa, Loretta M Parker, Kamila Krol, Meng Zhao

Abstract read
In one paragraph

Article in ImmunoHorizons, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Maday G FigueroaArthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK.
Loretta M ParkerArthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK.ORCID 0000-0002-2869-0432
Kamila KrolArthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK.
Meng ZhaoArthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK; meng-zhao@omrf.org.ORCID 0000-0001-6392-4954

Funding

Viral sensor IFIH1 promotes SLE through an altered interferon programP20GM139763 · NIGMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI Lijun Xia · 2021 to 2026
$20.3M
Oklahoma Rheumatic Disease Research Cores Center (Overall Application)P30AR073750 · NIAMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI JUDITH A JAMES · 2018 to 2026
$8.5M
cGMP Manufacture, Fill-Finish, Release, Analytical and Stability Testing and Stability Program of a Nanoparticle Based HIV Envelope Vaccine75N93022D00005 · NIAID · INTERNATIONAL AIDS VACCINE INITIATIVE · PI HASSELL, THOMAS · 2022 to 2025
$8.0M
Task Area A shall encompass annual follow-up of cohort members, clinical events investigations, study operations, and data analysis and manuscript writing. If implemented, Task A.1 will provide fundin75N92020D00005 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WATSON, KAROL E · 2020 to 2025
$5.1M
Resource-based Center for the study of the joint microenvironment in rheumatology (Overall Application)P30AR073761 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CORR, MARY P · 2018 to 2022
$3.9M
5-Laser Cytek Aurora Spectral Flow CytometerS10OD028479 · OD · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI THOMPSON, LINDA F · 2020 to 2020
$317k
NHLBI NIH HHS 75N92020D00005NIAID NIH HHS 75N93022D00005NIAID NIH HHS 75N93023D00005NIAMS NIH HHS P30 AR073750NIAMS NIH HHS P30 AR073761NIDA NIH HHS 75N95020D00005NIGMS NIH HHS P20 GM139763NIH HHS S10 OD028479ORFDO NIH HHS 75N99020D00005
6 · The paper itself

Abstract

Innate-like T cells, including invariant NKT cells, mucosal-associated invariant T (MAIT) cells, and γ δ T (γδT) cells, are groups of unconventional T lymphocytes. They play important roles in the immune system. Because of the lack of Cre recombinase lines that are specific for innate-like T cells, pan-T cell Cre lines are often used to study innate-like T cells. In this study, we found that distal Lck promoter-driven Cre (dLckCre) in which the distal

Indexed as

AnimalsCell DifferentiationCell SeparationFlow CytometryGenes, ReporterIntegrasesIntraepithelial LymphocytesLuminescent ProteinsLymphocyte Specific Protein Tyrosine Kinase p56(lck)MiceMice, TransgenicMucosal-Associated Invariant T CellsNatural Killer T-CellsPromoter Regions, GeneticRed Fluorescent ProteinCre recombinaseIntegrasesLuminescent ProteinsLymphocyte Specific Protein Tyrosine Kinase p56(lck)Red Fluorescent Protein

Identifiers

PMID34583938
PMCPMC8612026

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.